Skip to main content

Expanding Access to Investigational Therapies for HIV Infection and AIDS (1991) / Chapter Skim
Currently Skimming:

CONFERENCE PROGRAM
Pages 1-4

The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.


From page 1...
... Moderator: J Richard Crout, Vice President, Medical and Scientific Affairs, Boehringer Mannheim Pharmaceuticals Panelists: Robert Temple, Director, Office of Drug Evaluation I, Food and Drug Administration Jay Lipner, Partner, Silverstein Langer Lipner & Newburgh Stephen Sherwin, Vice President for Clinical Research, Genentech, Inc.
Read the entire page →
From page 2...
... David Higbee, Branch Chief, Catastrophic Medical SeIvices, Office of Coverage Policy, Health Care Financing Administration Susan Gleeson, Executive Director, Technology Management, Blue Cross and Blue Shield Association Steven Peskin, Vice President and Medical Director, CIGNA Healthplan of Texas, Inc.
Read the entire page →
From page 3...
... Moderator: Gerald Friedland, Professor of Medicine, Epidemiology, and Social Medicine, Albert Einstein College of Medicine Panelists: Lawrence Brown, Jr., Senior Vice President for Research and Medical Affairs, Addiction Research and Treatment Corporation Mark Smith, Associate Director, AIDS Service, Johns Hopkins University School of Medicine Deborah Cotton, Clinical Director for AIDS, Beth Israel Hospital
Read the entire page →
From page 4...
... 4 PROGRAM Philip Pizzo, Chief, Pediatric Branch, National Cancer Institute 9:30 Discussion 10:15 Parallel Track: An Update - James Allen, Director, National AIDS Program Office, Public Health Service 10:30 Parallel Track: What Should It Achieve? Moderator: Anthony Fauci, Associate Director for AIDS Research, National Institutes of Health, and Director, National Institute of Allergy and Infectious Diseases Panelists: Louis Lasagna, Dean, Sackler School of Graduate Biomedical Sciences, Tufts University James Eigo, Member, Treatment and Data Committee, AIDS Coalition to Unleash Power Daniel Hoth, Director, Division of AIDS, National Institute of Allergy and Infectious Diseases Ellen Cooper, Director, Division of Antiviral Drug Products, Food and Drug Administration 11:45 Discussion Expanding Access and the Needs of the Traditional Primary Care Provider - HaIvey Makadon, Assistant Professor of Medicine, Harvard Medical School, and Executive Director, Boston AIDS Consortium Discussion Summation - Sheldon Wolff, Endicott Professor and Chairman, Department of Medicine, Tufts University School of Medicine, and Cochair, AIDS Roundtable 1:00 Adjournment
Read the entire page →

Key Terms

  • infectious diseases
  • executive vice
  • david higbee
  • aids service
  • lawrence brown

  • patrick gage
  • care financing
  • administration susan
  • jerome birnbaum
  • susan gleeson

  • mark smith
  • treatment corporation
  • financing administration
  • coverage policy
  • cigna healthplan

  • mannheim pharmaceuticals
  • steven peskin
  • blue cross
  • biostatistics research
  • medical director

  • branch chief
  • blue shield
  • research branch
  • richard crout
  • addiction research

  • technology management
  • catastrophic medical
  • scientific affairs
  • genetics institute
  • boehringer mannheim


    • This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
    More information on Chapter Skim is available.